ABCL | AbCellera Biologics Inc.

Healthcare | Biotechnology | Canada | NASD

Index	-	P/E	-	EPS (ttm)	-0.18	Insider Own	19.70%	Shs Outstand	287.77M	Perf Week	-1.74%
Market Cap	1.96B	Forward P/E	-	EPS next Y	-0.66	Insider Trans	0.45%	Shs Float	203.83M	Perf Month	3.03%
Income	-50.20M	PEG	-	EPS next Q	-0.13	Inst Own	46.90%	Short Float / Ratio	13.06% / 13.02	Perf Quarter	-18.97%
Sales	181.00M	P/S	10.83	EPS this Y	4.40%	Inst Trans	11.32%	Short Interest	26.62M	Perf Half Y	-47.24%
Book/sh	4.20	P/B	1.62	EPS next Y	-11.90%	ROA	-3.20%	Target Price	26.67	Perf Year	-12.95%
Cash/sh	0.67	P/C	10.16	EPS next 5Y	10.00%	ROE	-4.10%	52W Range	5.53 - 14.97	Perf YTD	-32.97%
Dividend	-	P/FCF	32.67	EPS past 5Y	-	ROI	11.00%	52W High	-54.64%	Beta	-
Dividend %	-	Quick Ratio	10.50	Sales past 5Y	-	Gross Margin	-	52W Low	22.78%	ATR	0.41
Employees	495	Current Ratio	10.50	Sales Q/Q	-96.10%	Oper. Margin	-40.50%	RSI (14)	53.90	Volatility	6.10% 6.83%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-125.80%	Profit Margin	-27.70%	Rel Volume	1.15	Prev Close	6.79
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 04 AMC	Payout	0.00%	Avg Volume	2.05M	Price	6.79
Recom	1.80	SMA20	8.05%	SMA50	-0.49%	SMA200	-29.62%	Volume	2,357,438	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-28-23	Initiated	Cowen	Outperform
Dec-15-22	Initiated	Goldman	Buy	$30
Nov-16-22	Initiated	Truist	Buy	$29
Dec-21-21	Initiated	The Benchmark Company	Buy	$27
Nov-19-21	Initiated	Piper Sandler	Overweight	$33
Jan-05-21	Initiated	SVB Leerink	Outperform	$45
Jan-05-21	Initiated	Stifel	Buy	$59
Jan-05-21	Initiated	Credit Suisse	Outperform	$52
Jan-05-21	Initiated	BMO Capital Markets	Outperform	$48
Jan-05-21	Initiated	Berenberg	Buy	$53

May-30-23 06:50AM	Daily Vickers Top Buyers & Sellers for 05/30/2023 (Argus Research)
May-29-23 04:05PM	AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023 (Business Wire)
May-27-23 08:43AM	Strong week for AbCellera Biologics (NASDAQ:ABCL) shareholders doesn't alleviate pain of one-year loss (Simply Wall St.)
May-24-23 02:32PM	UPDATE 1-AbCellera to make C$701 million co-investment in Canada (Reuters)
01:56PM	AbCellera to make C$701 million co-investment in Canada (Reuters)
01:30PM	Loading…
01:30PM	These Small-Cap Biotech Stocks Have the Wind at Their Back (TheStreet.com)
01:10PM	AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients (Business Wire)
May-14-23 02:57PM	7 Growth Stocks That Could Double Your Money in 2023 (InvestorPlace)
May-06-23 08:03AM	AbCellera Biologics First Quarter 2023 Earnings: EPS Misses Expectations (Simply Wall St.)
May-05-23 10:13AM	Q1 2023 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents) -9.38%
12:30AM	AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript (Motley Fool)
May-04-23 05:15PM	AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-27-23 10:02AM	AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-24-23 07:46PM	7 Stocks Under $10 That Analysts Love (InvestorPlace)
Apr-17-23 09:10AM	AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023 (Business Wire)
05:50AM	Loading…
Apr-13-23 05:50AM	1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy (Motley Fool)
Apr-11-23 07:31PM	7 Best Stocks Under $10 to Buy in April (InvestorPlace)
04:05PM	AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023 (Business Wire)
Apr-06-23 04:05PM	AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023 (Business Wire)
Apr-05-23 01:40PM	7 Thrilling Biotech Stocks for Aggressive Investors to Buy (InvestorPlace)
Mar-22-23 03:26PM	7 Stocks to Bet On if You Want to Be Richer Than Elon Musk (InvestorPlace)
09:00AM	AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease (Business Wire)
Mar-14-23 04:30PM	AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023 (Business Wire)
Mar-12-23 08:09AM	Institutional investors may adopt severe steps after AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 9.9% drop adds to a year losses (Simply Wall St.)
Feb-23-23 04:05PM	AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023 (Business Wire)
Feb-21-23 10:30PM	AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript (Motley Fool) -7.30%
05:45PM	AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Full Year 2022 Business Results (Business Wire)
Feb-02-23 02:19PM	The 7 Most Undervalued Biotech Stocks to Buy in February 2023 (InvestorPlace)
Feb-01-23 04:05PM	AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023 (Business Wire)
04:05PM	Loading…
Jan-24-23 04:05PM	AbCellera to Report Full Year 2022 Financial Results on February 21, 2023 (Business Wire)
08:48AM	Is the Options Market Predicting a Spike in AbCellera (ABCL) Stock? (Zacks)
Jan-23-23 11:00AM	AbCellera Biologics Clears Key Benchmark, Hitting 80-Plus RS Rating (Investor's Business Daily)
Jan-19-23 07:00PM	AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent (Business Wire)
11:59AM	Does AbCellera Biologics (NASDAQ:ABCL) Deserve A Spot On Your Watchlist? (Simply Wall St.)
Jan-12-23 04:55AM	Strength Seen in Pliant Therapeutics, Inc. (PLRX): Can Its 8.3% Jump Turn into More Strength? (Zacks) +6.25%
Jan-05-23 09:09AM	AbCellera Biologics Inc.'s (NASDAQ:ABCL) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Jan-04-23 04:05PM	AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023 (Business Wire)
Dec-22-22 05:08AM	Trade Alert: The CEO, President & Chairperson Of AbCellera Biologics Inc. (NASDAQ:ABCL), Carl Hansen, Has Just Spent US$859k Buying A Few More Shares (Simply Wall St.)
Dec-21-22 06:46AM	Daily Vickers Top Buyers & Sellers for 12/21/2022 (Argus Research)
Dec-16-22 10:02AM	AbCellera (ABCL) to Develop New Antibody Therapies With AbbVie (Zacks)
Dec-15-22 07:00AM	AbCellera and AbbVie Partner to Advance New Antibody Therapies (Business Wire)
Dec-14-22 08:18AM	Is There An Opportunity With AbCellera Biologics Inc.'s (NASDAQ:ABCL) 43% Undervaluation? (Simply Wall St.)
Dec-12-22 08:54AM	Implied Volatility Surging for AbCellera Biologics (ABCL) Stock Options (Zacks)
Dec-01-22 07:00AM	AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases (Business Wire)
04:00AM	AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases (Business Wire)
Nov-29-22 04:10PM	IBD Stock Of The Day AbCellera Is Pulling Back Why Investors Should Be Paying Attention (Investor's Business Daily)
Nov-10-22 08:05AM	AbCellera Presents New Data on Further Development and Characterization of T-Cell Engager Platform at SITC 2022 (Business Wire) +9.31%
Nov-08-22 11:00PM	AbCellera Biologics Inc. (ABCL) Q3 2022 Earnings Call Transcript (Motley Fool)
06:35PM	AbCellera Biologics Inc. (ABCL) Q3 Earnings Miss Estimates (Zacks)
04:05PM	AbCellera Reports Q3 2022 Business Results (Business Wire)
Nov-04-22 04:05PM	AbCellera to Present at Upcoming Investor Conferences in November (Business Wire)
Nov-03-22 01:45PM	Abcellera Biologics Clears Technical Benchmark, Hitting 90-Plus RS Rating (Investor's Business Daily)
Nov-02-22 09:00AM	AbCelleras First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development (Business Wire)
Nov-01-22 10:01AM	AbCellera Biologics Inc. (ABCL) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-25-22 02:45PM	12 Best Stocks Under $50 (Insider Monkey)
Oct-21-22 09:55AM	Wall Street Analysts Believe AbCellera Biologics Inc. (ABCL) Could Rally 138%: Here's is How to Trade (Zacks)
Oct-11-22 04:05PM	AbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022 (Business Wire)
10:40AM	Abcellera Biologics Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily)
Oct-10-22 08:48AM	Implied Volatility Surging for AbCellera Biologics (ABCL) Stock Options (Zacks)
Oct-05-22 09:25AM	11 Cheap Healthcare Stocks To Invest In (Insider Monkey)
08:00AM	AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022 (Business Wire)
Oct-03-22 06:45AM	AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners may be pleased with recent gains after 43% loss over the past year (Simply Wall St.)
Sep-26-22 09:21AM	10 Best Biotech Stocks Under $10 (Insider Monkey)
Sep-21-22 08:00AM	AbCellera Launches Second Phase of Global Headquarters Expansion to Advance Capabilities for Bringing New Medicines from Target to the Clinic (Business Wire)
Aug-24-22 06:15AM	CEO, President & Chairperson Carl Hansen Just Bought A Handful Of Shares In AbCellera Biologics Inc. (NASDAQ:ABCL) (Simply Wall St.)
Aug-18-22 08:50AM	Implied Volatility Surging for AbCellera (ABCL) Stock Options (Zacks)
Aug-10-22 01:20PM	Why AbCellera Biologics Rallied as Much as 24% on Wednesday (Motley Fool) +20.07%
12:30AM	AbCellera Biologics Inc. (ABCL) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-09-22 06:05PM	AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -5.53%
04:05PM	AbCellera Reports Q2 2022 Business Results (Business Wire)
Aug-04-22 10:00AM	Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: Should You Buy? (Zacks)
Aug-03-22 07:00AM	AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients (Business Wire)
Aug-02-22 10:00AM	AbCellera Biologics Inc. (ABCL) Earnings Expected to Grow: Should You Buy? (Zacks) +5.67%
Jul-27-22 11:15AM	Abcellera Biologics Stock Sees Relative Strength Rating Jump To 89 (Investor's Business Daily)
07:00AM	Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies (Business Wire)
Jul-12-22 04:05PM	AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022 (Business Wire)
Jul-11-22 10:14AM	Is AbCellera Biologics Inc.'s (NASDAQ:ABCL) Recent Stock Performance Tethered To Its Strong Fundamentals? (Simply Wall St.)
Jun-29-22 11:04AM	Lilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment Options (Business Wire)
Jun-23-22 08:52AM	Insiders rewarded with a US$7.1m addition on top of their US$20m purchase as AbCellera Biologics Inc. (NASDAQ:ABCL) hits US$2.9b (Simply Wall St.)
Jun-20-22 08:53AM	AbCellera Biologics Inc. (ABCL) Stock Jumps 9.3%: Will It Continue to Soar? (Zacks)
Jun-05-22 08:21AM	AbCellera Biologics (NASDAQ:ABCL) stock falls 4.6% in past week as one-year earnings and shareholder returns continue downward trend (Simply Wall St.)
May-25-22 03:00PM	Masayoshi Son is Selling These 9 Stocks in 2022 (Insider Monkey)
May-13-22 06:06AM	Analysts Just Shipped A Massive Upgrade To Their AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates (Simply Wall St.) +7.75%
May-11-22 12:54PM	Why AbCellera Biologics Is 10% Lower Today (Motley Fool) -13.86%
May-10-22 05:45PM	AbCellera Biologics Inc. (ABCL) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q1 2022 Business Results (Business Wire)
May-09-22 09:37AM	Ring Energy (REI) to Report Q1 Earnings: What's in Store? (Zacks) -12.63%
May-03-22 03:00PM	AbCellera Biologics Inc. (ABCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:00AM	AbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery Collaboration (Business Wire)
Apr-26-22 04:05PM	AbCellera to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022 (Business Wire) -6.20%
07:17AM	3 Biotech Stocks Under $10 to Add to Your Buy List (InvestorPlace)
Apr-25-22 01:23PM	What Percentage Of AbCellera Biologics Inc. (NASDAQ:ABCL) Shares Do Insiders Own? (Simply Wall St.)
Apr-12-22 04:05PM	AbCellera to Report First Quarter 2022 Financial Results on May 10, 2022 (Business Wire)
Apr-08-22 01:05PM	AbCellera Presents Data on T Cell Engager Platform at AACR 2022 (Business Wire) -7.28%
Feb-25-22 07:00AM	AbCellera Biologics Inc. (ABCL) Q4 2021 Earnings Call Transcript (Motley Fool) +5.68%
Feb-24-22 04:05PM	AbCellera Reports Full Year 2021 Business Results (Business Wire)
Feb-23-22 04:05PM	AbCellera to Participate Virtually in the Truist Securities AI Symposium Biotech & Tools (Business Wire) -6.24%
Feb-11-22 06:58PM	AbCellera-Discovered Antibody, Bebtelovimab, Receives U.S. FDA Emergency Use Authorization for the Treatment of Mild-to-Moderate COVID-19 (Business Wire)
04:05PM	AbCellera to Present Virtually at the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022 (Business Wire)

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hansen Carl L. G.	Chief Executive Officer	May 26	Option Exercise	2.70	56,125	151,538	561,250	May 30 01:14 PM
Thermopylae Holdings Ltd.	10% Owner	May 26	Buy	6.52	153,000	997,728	56,012,493	May 26 02:50 PM
Booth Andrew	Chief Financial Officer	May 26	Buy	6.85	14,500	99,325	153,000	May 26 02:53 PM
Lecault Veronique	Chief Operating Officer	May 05	Option Exercise	0.19	250,000	47,500	2,020,122	May 09 03:02 PM
Hansen Carl L. G.	Chief Executive Officer	Feb 22	Option Exercise	2.70	56,125	151,538	505,125	Feb 23 04:33 PM
Booth Andrew	Chief Financial Officer	Dec 20	Option Exercise	0.19	50,000	9,500	188,500	Dec 22 02:31 PM
Thermopylae Holdings Ltd.	10% Owner	Dec 16	Buy	10.10	85,102	859,249	55,859,493	Dec 20 10:18 AM
Hansen Carl L. G.	Chief Executive Officer	Nov 18	Option Exercise	2.70	56,125	151,538	449,000	Nov 21 09:36 PM
Thermopylae Holdings Ltd.	10% Owner	Aug 19	Buy	11.46	200,000	2,292,460	55,844,391	Aug 22 03:27 PM
Hansen Carl L. G.	Chief Executive Officer	Aug 18	Option Exercise	2.70	56,125	151,538	392,875	Aug 22 03:09 PM
Thermopylae Holdings Ltd.	10% Owner	Jun 14	Buy	8.05	9,173	73,842	55,644,391	Jun 15 01:14 PM
Thermopylae Holdings Ltd.	10% Owner	Jun 13	Buy	8.03	54,915	441,066	55,635,218	Jun 15 01:14 PM
Thermopylae Holdings Ltd.	10% Owner	Jun 06	Buy	7.50	64,545	483,965	55,580,303	Jun 08 03:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABCL | AbCellera Biologics Inc.

Upgrade your FINVIZ experience